4.9.6Segment

Life Sciences Consulting & Advisory

Regulatory affairs, pharmacovigilance, and quality consulting firms supporting pharmaceutical and biotech clients.

4
Verticals

Overview

Life Sciences Consulting & Advisory covers regulatory-affairs, pharmacovigilance, quality, and commercial-strategy consulting firms supporting pharmaceutical and biotech clients. It helps companies navigate FDA and global regulatory pathways, safety and quality requirements, and market access and commercialization.

Demand is driven by regulatory complexity, the volume of drug-development activity, and the specialized capability sponsors lack in-house. It overlaps clinical-research and commercial-analytics services (IQVIA and peers), and is consolidating as firms build scale across the development-to-commercialization journey.

Market snapshot

FragmentationFragmented

Not cleanly Census-coded — the mapped biotech-R&D code (541714, ~$91B) measures research activity, not consulting; life-sciences consulting proper sits within management/technical consulting, so it is not sized here.

Business model & economics

Revenue model
Advisory project and managed-service fees
Recurring revenue
Moderate — recurring regulatory and pharmacovigilance work
EBITDA margin
18–30%
Capex intensity
Low
  • Navigates regulatory, safety, and market-access complexity.
  • Demand tracks drug-development activity.
  • Overlaps clinical-research and commercial-analytics services.

M&A deal context

Moderate deal activity

Who’s acquiring

Life-sciences-services platformsCRO & analytics strategicsPE-backed advisory roll-ups

What’s driving deals

  • Consolidation across development-to-commercialization services.
  • Regulatory complexity driving demand.
  • Drug-development-activity-driven volume.

Verticals in this segment

  • 4.9.6.1Medical Affairs & Publications

    Consultancies supporting clinical publication and medical affairs.

  • 4.9.6.2Pharmacovigilance & Safety Services

    Firms managing adverse event reporting and drug safety compliance.

  • 4.9.6.3Quality Assurance & Regulatory Affairs

    Consultancies supporting pharmaceutical QA and regulatory submissions.

  • 4.9.6.4Regulatory Strategy & Submissions

    Firms advising on FDA submissions and regulatory strategy.

Find Life Sciences Consulting & Advisory acquisition targets

Search Acquisera’s index for companies classified under Life Sciences Consulting & Advisory (4.9.6) and build a targeted deal pipeline.

Search companies